Amalia De Renzo Selected Research

Amalia De Renzo Research Topics

Disease

11	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2020 - 01/2002
6	Lymphoma (Lymphomas) 08/2020 - 11/2003
5	Infections 01/2016 - 08/2003
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2016 - 07/2004
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2010 - 11/2009
2	Febrile Neutropenia 01/2019 - 01/2017
2	Hodgkin Disease (Hodgkin's Disease) 10/2017 - 09/2007
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2015 - 02/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2008 - 12/2002
2	Multiple Myeloma 04/2004 - 04/2002
2	Hepatitis 11/2003 - 01/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2017
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2016
1	Lung Diseases (Lung Disease) 06/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2015
1	Glomerulonephritis 06/2015
1	Paraproteinemias (Monoclonal Gammopathy) 06/2015
1	Arthritis (Polyarthritis) 06/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 06/2015
1	Dermatitis 06/2015
1	Arthralgia (Joint Pain) 06/2015
1	Cryoglobulinemia 06/2015
1	Vasculitis (Vasculitides) 06/2015
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2012
1	Carcinoma (Carcinomatosis) 09/2007
1	Neoplasms (Cancer) 09/2007
1	Pathologic Complete Response 07/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2004
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2003
1	Sclerosis 12/2002
1	Critical Illness (Critically Ill) 06/2002

Drug/Important Bio-Agent (IBA)

10	Rituximab (Mabthera)FDA Link 08/2020 - 07/2004
4	Antiviral Agents (Antivirals)IBA 01/2018 - 08/2003
4	fludarabineIBA 06/2016 - 11/2003
3	Bendamustine Hydrochloride FDA Link 08/2020 - 01/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2020 - 04/2002
3	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2016 - 07/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2020 - 11/2009
2	Prednisone (Sone)FDA LinkGeneric 08/2020 - 11/2009
2	Vincristine (Oncovin)FDA LinkGeneric 08/2020 - 11/2009
2	pegfilgrastim (Neulasta)FDA Link 01/2019 - 01/2017
2	Brentuximab VedotinIBA 11/2017 - 10/2017
2	ibritumomab tiuxetan (Zevalin)FDA Link 06/2016 - 04/2008
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2014 - 11/2003
2	Lamivudine (Epivir)FDA Link 11/2003 - 01/2002
1	Glucose (Dextrose)FDA LinkGeneric 06/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ibrutinibIBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Immunoglobulin M (IgM)IBA 06/2015
1	AntigensIBA 06/2015
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2015
1	Interferon-alpha (Interferon Alfa)IBA 06/2015
1	Rheumatoid FactorIBA 06/2015
1	Ribavirin (Virazole)FDA LinkGeneric 06/2015
1	Explosive Agents (Explosives)IBA 06/2015
1	AutoantibodiesIBA 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2012
1	NF-kappa B (NF-kB)IBA 04/2012
1	VaccinesIBA 02/2010
1	FluorineIBA 01/2010
1	YttriumIBA 01/2010
1	Methotrexate (Mexate)FDA LinkGeneric 11/2009
1	AnthracyclinesIBA 10/2008
1	Yttrium-90IBA 04/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2004
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 03/2004
1	Hepatitis C AntibodiesIBA 01/2004
1	RNA (Ribonucleic Acid)IBA 01/2004

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2018 - 04/2002
8	Therapeutics 06/2016 - 04/2003
3	Radioimmunotherapy 06/2016 - 04/2008
2	Radiotherapy 09/2007 - 12/2002
1	Salvage Therapy 01/2018
1	Immunotherapy 01/2016
1	Drug Tapering 06/2015
1	Central Venous Catheters 03/2004
1	Stem Cell Transplantation 04/2003
1	Induction Chemotherapy 12/2002
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2002